Inspire Medical Systems targets $940M-$955M revenue in 2025 with Inspire V launch
Q4 2024 Management View CEO Tim Herbert highlighted milestones in 2024, including surpassing 90,000 patients treated with Inspire therapy, FDA approval of the Inspire V neurostimulator, and achieving ...
Hosted on MSN19m
Kraft Heinz Stock Slips On Analyst Downgrade Ahead of Q4 Earnings, But Retail's Bullish
Shares of The Kraft Heinz Co. ($KHC) fell 1.16% on Monday as Mizuho downgraded the company’s stock ahead of its Q4 earnings, ...